PT Metro Healthcare Indonesia Tbk's quarterly market cap
increased
from Sep. 2025 (Rp9,642,500 Mil) to Dec. 2025 (Rp22,610,000 Mil) but then
declined
from Dec. 2025 (Rp22,610,000 Mil) to Mar. 2026 (Rp13,632,500 Mil).
PT Metro Healthcare Indonesia Tbk's annual market cap
increased
from Dec. 2023 (Rp5,320,000 Mil) to Dec. 2024 (Rp6,284,250 Mil) and
increased
from Dec. 2024 (Rp6,284,250 Mil) to Dec. 2025 (Rp22,610,000 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PT Metro Healthcare Indonesia Tbk's Enterprise Value for Today is Rp14,433,715 Mil.
PT Metro Healthcare Indonesia Tbk (ISX:CARE) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PT Metro Healthcare Indonesia Tbk Market Cap Related Terms
PT Metro Healthcare Indonesia Tbk Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Metro Healthcare Indonesia Tbk Market Cap Chart
For the Medical Care Facilities subindustry, PT Metro Healthcare Indonesia Tbk's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Metro Healthcare Indonesia Tbk Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Metro Healthcare Indonesia Tbk's Market Cap distribution charts can be found below:
* The bar in red indicates where PT Metro Healthcare Indonesia Tbk's Market Cap falls into.
PT Metro Healthcare Indonesia Tbk Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Metro Healthcare Indonesia Tbk (ISX:CARE) has a Market Cap of Rp13,832,000 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. According to the industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #157 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 22.6%.
Is PT Metro Healthcare Indonesia Tbk's Market Cap too high?
PT Metro Healthcare Indonesia Tbk's current Market Cap is Rp13,832,000 Mil. Based on the distribution chart, PT Metro Healthcare Indonesia Tbk ranks #157 out of 695 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, PT Metro Healthcare Indonesia Tbk has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Metro Healthcare Indonesia Tbk's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #157 out of 695 companies for Market Cap. This places PT Metro Healthcare Indonesia Tbk in the top 23% of its industry — outperforming the majority of peers. The industry median Market Cap is 96.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 96.57, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 96.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Metro Healthcare Indonesia Tbk's current Market Cap is Rp13,832,000 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Metro Healthcare Indonesia Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk (ISX:CARE) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp366.04, compared to a current price of Rp420.00 — trading 14.7% above its estimated fair value. The current Market Cap is Rp13,832,000 Mil. PT Metro Healthcare Indonesia Tbk's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PT Metro Healthcare Indonesia Tbk (ISX:CARE), the current Market Cap is Rp13,832,000 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued.
The current stock price of Rp420.00 is trading 14.7% above its estimated GF Value™ of Rp366.04.
GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Modestly Overvalued.
Key valuation signals for ISX:CARE:
Market Cap: Rp13,832,000 Mil
GF Value™: Rp366.04 vs. price of Rp420.00 (14.7% above fair value)
No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Metro Healthcare Indonesia Tbk Business Description
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
77GF Score
Get the complete analysis for ISX:CARE
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:CARE has been successfully added to your 
